The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of bevacizumab combined with concurrent chemoradiation for squamous cell carcinoma of the head and neck: Preliminary outcome results.
P. M. Harari
No relevant relationships to disclose
D. Khuntia
No relevant relationships to disclose
A. M. Traynor
No relevant relationships to disclose
T. Hoang
No relevant relationships to disclose
D. T. Yang
No relevant relationships to disclose
G. K. Hartig
No relevant relationships to disclose
T. M. McCulloch
No relevant relationships to disclose
R. Jeraj
No relevant relationships to disclose
M. J. Nyflot
No relevant relationships to disclose
P. A. Wiederholt
No relevant relationships to disclose
L. R. Gentry
No relevant relationships to disclose